Figshareopen access
Discovery of
an Orally Available Potent ER Aminopeptidase
1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory
Autoimmunity In Vivo
biochemistry, medicine, genetics, pharmacology, biotechnology, immunology, cancer, infectious diseases
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 298388
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.